Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.41 |
| ▸ | RET | P07949 | 6/20 | 0.41 |
| ▸ | TLK2 | Q86UE8 | 3/20 | 0.39 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.37 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 2/20 | 0.35 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.34 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.34 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.34 |
| ▸ | CDK2 | P24941 | 2/20 | 0.34 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7473409 | 0.84 | TLK2 (0.44) | BRD4RETTLK2NTRK1NTRK3 | |
| SCHEMBL6337672 | 0.80 | RET (0.41) | BRD4RETTLK2GSK3BNOX4 | |
| SCHEMBL7480182 | 0.80 | RET (0.45) | BRD4RETTLK2NTRK1CHEK1 | |
| SCHEMBL7472918 | 0.79 | RET (0.54) | BRD4RETTLK2NTRK3GSK3B | |
| SCHEMBL479649 | 0.77 | RXFP1 (0.36) | RETGSK3B | |
| SCHEMBL479654 | 0.77 | RXFP1 (0.36) | RETGSK3B | |
| SCHEMBL7474781 | 0.77 | RET (0.50) | BRD4RETTLK2GSK3BNOX4 | |
| SCHEMBL7480965 | 0.76 | RET (0.45) | BRD4RETTLK2NTRK1NTRK3 | |
| SCHEMBL7475213 | 0.76 | RET (0.43) | BRD4RETTLK2NTRK1NTRK3 | |
| SCHEMBL7473364 | 0.76 | RET (0.47) | BRD4RETTLK2GSK3BNOX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1212318-A1 | SUBSTITUTED INDOLINONES AS TYROSINE KINASE INHIBITORS | Boehringer Ingelheim Pharma KG (DE) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001016130-A1 | SUBSTITUTED INDOLINONES AS TYROSINE KINASE INHIBITORS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2001-03-08 | — | — | WO | disclosed |